Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly-Reference-Cited by-同舟云学术

Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly

Published:1992-09 Issue:s1 Volume:17 Page:44-49
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:Clin Exp Dermatol

Author:

REINEL D.,CLARKE C.

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2230.1992.tb00278.x/fullpdf

Reference13 articles.

1. 1. A. Polak, Experimental activity of a new antimycotic. Current chemotherapy and immunotherapy . Proceedings of the 12th International Congress on ChemotherapyFlorence, 19-24 July1981 ; 1023 -25 .

2. In-vitro studies with four new antifungal agents: BAY n7133, bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002

3. Antifungal activityin vitroof Ro 14-4767/002, a phenylpropyl-morpholine

4. Amorolfine

5. Antifungal activity of four antifungal drugs in the cutaneous retention time test

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Penetration Profiles of Four Topical Antifungals in Mycotic Human Toenails Quantified by Matrix-Assisted Laser Desorption Ionization–Fourier Transform Ion Cyclotron Resonance Imaging;Infectious Diseases and Therapy;2024-05-04

2. How effective is topical miconazole or amorolfine for mild to moderately severe onychomycosis in primary care: the Onycho Trial – a randomised double-blind placebo-controlled trial;BMJ Open;2024-05

3. Antifungal Selection for the Treatment of Onychomycosis: Patient Considerations and Outcomes;Infection and Drug Resistance;2024-03

4. A randomized comparative study of fractional carbon dioxide laser-assisted drug delivery with amorolfine versus amorolfine alone for the treatment of onychomycosis;Egyptian Journal of Dermatology and Venerology;2022

5. Race reporting and representation in onychomycosis clinical trials: A systematic review;Mycoses;2021-03-13